Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle -- Taylor et al. 329 (7472): 972 Data Supplement - References w1 - w16, further details and figures showing the effect on drug prices -- BMJ

Jump to: Page Content, Site Navigation, Site Search,

You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
BMJ Taylor et al. 329: 972

References w1 - w16, further details and figures showing the effect on drug prices

Files in this Data Supplement:

This Article

Services

Email this article to a friend

What's new

Latest blogs

Find BMJ on:

Services

Tools

Email to friend

Print this page

Online poll

Find out more>>

Resources

Rapid responses for this article

There are no rapid responses for this article.

Print issues

Specialist Libraries' Association
top 100 journal

Access jobs at BMJ Careers

Whats new online at Student

BMJ

Contact us - Privacy policy - Web site terms & conditions - Revenue sources - Site map

HighWire Press - Feedback - Help - © 2009 BMJ Publishing Group Ltd.